Skip to main content
Erschienen in: Endocrine 1/2018

12.07.2017 | Original Article

Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism

verfasst von: A. Concistrè, A. Grillo, G. La Torre, R. Carretta, B. Fabris, L. Petramala, C. Marinelli, A. Rebellato, F. Fallo, C. Letizia

Erschienen in: Endocrine | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Primary hyperparathyroidism is associated with a cluster of cardiovascular manifestations, including hypertension, leading to increased cardiovascular risk.

Purpose

The aim of our study was to investigate the ambulatory blood pressure monitoring-derived short-term blood pressure variability in patients with primary hyperparathyroidism, in comparison with patients with essential hypertension and normotensive controls.

Methods

Twenty-five patients with primary hyperparathyroidism (7 normotensive,18 hypertensive) underwent ambulatory blood pressure monitoring at diagnosis, and fifteen out of them were re-evaluated after parathyroidectomy. Short-term-blood pressure variability was derived from ambulatory blood pressure monitoring and calculated as the following: 1) Standard Deviation of 24-h, day-time and night-time-BP; 2) the average of day-time and night-time-Standard Deviation, weighted for the duration of the day and night periods (24-h “weighted” Standard Deviation of BP); 3) average real variability, i.e., the average of the absolute differences between all consecutive BP measurements.

Results

Baseline data of normotensive and essential hypertension patients were matched for age, sex, BMI and 24-h ambulatory blood pressure monitoring values with normotensive and hypertensive-primary hyperparathyroidism patients, respectively. Normotensive-primary hyperparathyroidism patients showed a 24-h weighted Standard Deviation (P < 0.01) and average real variability (P < 0.05) of systolic blood pressure higher than that of 12 normotensive controls. 24-h average real variability of systolic BP, as well as serum calcium and parathyroid hormone levels, were reduced in operated patients (P < 0.001). A positive correlation of serum calcium and parathyroid hormone with 24-h-average real variability of systolic BP was observed in the entire primary hyperparathyroidism patients group (P = 0.04, P  = 0.02; respectively).

Conclusion

Systolic blood pressure variability is increased in normotensive patients with primary hyperparathyroidism and is reduced by parathyroidectomy, and may potentially represent an additional cardiovascular risk factor in this disease.
Literatur
1.
Zurück zum Zitat C. Marcocci, F. Cetani, Clinical practice. Primary hyperparathyroidism. N. Engl. J. Med. 365, 2389–2397 (2011)CrossRefPubMed C. Marcocci, F. Cetani, Clinical practice. Primary hyperparathyroidism. N. Engl. J. Med. 365, 2389–2397 (2011)CrossRefPubMed
2.
Zurück zum Zitat P. Andersson, E. Rydberg, R. Willenheimer, Primary hyperparathyroidism and heart disease-a review. Eur. Heart J. 25, 1776–1787 (2004)CrossRefPubMed P. Andersson, E. Rydberg, R. Willenheimer, Primary hyperparathyroidism and heart disease-a review. Eur. Heart J. 25, 1776–1787 (2004)CrossRefPubMed
3.
Zurück zum Zitat P. Luigi, F.M. Chiara, Z. Laura, M. Cristiano, C. Giuseppina, C. Luciano, P. Giuseppe, C. Sabrina, S. Susanna, C. Antonio, C. Giuseppe, T. Giorgio de, L. Claudio, Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results. Int. J. Endocrinol. 2012, 408295 (2012)CrossRefPubMedPubMedCentral P. Luigi, F.M. Chiara, Z. Laura, M. Cristiano, C. Giuseppina, C. Luciano, P. Giuseppe, C. Sabrina, S. Susanna, C. Antonio, C. Giuseppe, T. Giorgio de, L. Claudio, Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results. Int. J. Endocrinol. 2012, 408295 (2012)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat M. Curione, S. Amato, S. Di Bona, L. Petramala, D. Cotesta, C. Letizia, Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism. Int. J. Cardiol. 141(2), 201–202 (2010)CrossRefPubMed M. Curione, S. Amato, S. Di Bona, L. Petramala, D. Cotesta, C. Letizia, Parathyroidectomy erase increased myocardial electrical vulnerability in patients with primary hyperparathyroidism. Int. J. Cardiol. 141(2), 201–202 (2010)CrossRefPubMed
5.
Zurück zum Zitat E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)CrossRefPubMed E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)CrossRefPubMed
6.
Zurück zum Zitat C. Letizia, P. Ferrari, D. Cotesta, C. Caliumi, R. Cianci, S. Cerci, L. Petramala, M. Celi, S. Minisola, E. D’Erasmo, G.F. Mazzuoli, Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J. Hum. Hypertens. 19, 901–906 (2005)CrossRefPubMed C. Letizia, P. Ferrari, D. Cotesta, C. Caliumi, R. Cianci, S. Cerci, L. Petramala, M. Celi, S. Minisola, E. D’Erasmo, G.F. Mazzuoli, Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J. Hum. Hypertens. 19, 901–906 (2005)CrossRefPubMed
7.
Zurück zum Zitat T. Ohkubo, A. Hozawa, J. Yamaguchi, M. Kikuya, K. Ohmori, M. Michimata, M. Matsubara, J. Hashimoto, H. Hoshi, T. Araki, I. Tsuji, H. Satoh, S. Hisamichi, Y. Imai, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183–2196 (2002)CrossRefPubMed T. Ohkubo, A. Hozawa, J. Yamaguchi, M. Kikuya, K. Ohmori, M. Michimata, M. Matsubara, J. Hashimoto, H. Hoshi, T. Araki, I. Tsuji, H. Satoh, S. Hisamichi, Y. Imai, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183–2196 (2002)CrossRefPubMed
8.
Zurück zum Zitat G. Mancia, Short- and long-term blood pressure variability. Present and future. Hypertension 60, 512–517 (2012)CrossRefPubMed G. Mancia, Short- and long-term blood pressure variability. Present and future. Hypertension 60, 512–517 (2012)CrossRefPubMed
9.
Zurück zum Zitat M. Kikuya, A. Hozawa, T. Ohokubo, I. Tsuji, M. Michimata, M. Matsubara, M. Ota, K. Nagai, T. Araki, H. Satoh, S. Ito, S. Hisamichi, Y. Imai, Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36, 901–906 (2000)CrossRefPubMed M. Kikuya, A. Hozawa, T. Ohokubo, I. Tsuji, M. Michimata, M. Matsubara, M. Ota, K. Nagai, T. Araki, H. Satoh, S. Ito, S. Hisamichi, Y. Imai, Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 36, 901–906 (2000)CrossRefPubMed
10.
Zurück zum Zitat L. Mena, S. Pintos, N.V. Queipo, J.A. Aizpúrua, G. Maestre, T. Sulbarán, A reliable index for the prognostic significance of blood pressure variability. J. Hypertens. 23, 505–511 (2005)CrossRefPubMed L. Mena, S. Pintos, N.V. Queipo, J.A. Aizpúrua, G. Maestre, T. Sulbarán, A reliable index for the prognostic significance of blood pressure variability. J. Hypertens. 23, 505–511 (2005)CrossRefPubMed
11.
Zurück zum Zitat G. Bilo, A. Giglio, K. Styczkiewicz, G. Caldara, A. Maronati, K. Kawecka-Jaszcz, G. Mancia, G. Parati, A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J. Hypertens. 25, 2058–2066 (2007)CrossRefPubMed G. Bilo, A. Giglio, K. Styczkiewicz, G. Caldara, A. Maronati, K. Kawecka-Jaszcz, G. Mancia, G. Parati, A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J. Hypertens. 25, 2058–2066 (2007)CrossRefPubMed
12.
Zurück zum Zitat G. Parati, J.E. Ochoa, P. Salvi, C. Lombardi, G. Bilo, Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 36, S312–S324 (2013)CrossRefPubMedPubMedCentral G. Parati, J.E. Ochoa, P. Salvi, C. Lombardi, G. Bilo, Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 36, S312–S324 (2013)CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cifkova, G. De Backer, A. Dominiczak, M. Galderisi, D.E. Grobbee, T. Jaarsma, P. Kirchhof, S.E. Kjeldsen, S. Laurent, A.J. Manolis, P.M. Nilsson, L.M. Ruilope, R.E. Schmieder, P.A. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad; Task Force Members, ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013)CrossRefPubMed G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cifkova, G. De Backer, A. Dominiczak, M. Galderisi, D.E. Grobbee, T. Jaarsma, P. Kirchhof, S.E. Kjeldsen, S. Laurent, A.J. Manolis, P.M. Nilsson, L.M. Ruilope, R.E. Schmieder, P.A. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad; Task Force Members, ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013)CrossRefPubMed
14.
Zurück zum Zitat D.W. Cockroft, M.H. Gault, Prediction of creatinine clearance from serum creatinine. Nephron 16, 31–34 (1976)CrossRef D.W. Cockroft, M.H. Gault, Prediction of creatinine clearance from serum creatinine. Nephron 16, 31–34 (1976)CrossRef
15.
Zurück zum Zitat R. Eastell, M.L. Brand i, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3570–3579 (2014)CrossRefPubMed R. Eastell, M.L. Brand i, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3570–3579 (2014)CrossRefPubMed
16.
Zurück zum Zitat J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts, Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J. Clin. Endocrinol. Metab. 99, 3561–3569 (2014)CrossRefPubMedPubMedCentral J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts, Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the fourth international workshop. J. Clin. Endocrinol. Metab. 99, 3561–3569 (2014)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat C.A. Feldstein, M. Akopian, D. Pietrobelli, A. Olivieri, D. Garrido, Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism. Clin. Exp. Hypertens. 32(3), 154–158 (2010)CrossRefPubMed C.A. Feldstein, M. Akopian, D. Pietrobelli, A. Olivieri, D. Garrido, Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism. Clin. Exp. Hypertens. 32(3), 154–158 (2010)CrossRefPubMed
18.
Zurück zum Zitat P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98, E1583–E1590 (2013)CrossRefPubMed P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98, E1583–E1590 (2013)CrossRefPubMed
19.
Zurück zum Zitat V. Heyliger, C. Tangpricha, Weber, J. Sharma, Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 146(6), 1042–1047 (2009)CrossRefPubMedPubMedCentral V. Heyliger, C. Tangpricha, Weber, J. Sharma, Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 146(6), 1042–1047 (2009)CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat C. Gennari, R. Nami, S. Gonnelli, Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner. Electrolyte. Metab. 21(1–3), 77–81 (1995)PubMed C. Gennari, R. Nami, S. Gonnelli, Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner. Electrolyte. Metab. 21(1–3), 77–81 (1995)PubMed
21.
Zurück zum Zitat N.D. Vlachakis, R. Frederics, M. Velasquez, Sympathetic system function and vascular reactivity in hypercalcemic patients. Hypertension 4(3), 452–458 (1982)CrossRefPubMed N.D. Vlachakis, R. Frederics, M. Velasquez, Sympathetic system function and vascular reactivity in hypercalcemic patients. Hypertension 4(3), 452–458 (1982)CrossRefPubMed
22.
Zurück zum Zitat M. Kosch, M. Hausberg, K. Vormbrock, K. Kisters, G. Gabriels, K.H. Rahn, M. Barenbrock, Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res. 47(4), 813–818 (2000)CrossRefPubMed M. Kosch, M. Hausberg, K. Vormbrock, K. Kisters, G. Gabriels, K.H. Rahn, M. Barenbrock, Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res. 47(4), 813–818 (2000)CrossRefPubMed
23.
Zurück zum Zitat I.L. Nilsson, J. Åberg, J. Rastad, L. Lind, Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126(6), 1049–1055 (1999)CrossRefPubMed I.L. Nilsson, J. Åberg, J. Rastad, L. Lind, Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126(6), 1049–1055 (1999)CrossRefPubMed
24.
Zurück zum Zitat T. Neunteufl, S. Heher, G. Prager, R. Katzenschlager, C. Abela, B. Niederle, T. Stefenelli, Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin. Endocrinol. 53(2), 229–233 (2000)CrossRef T. Neunteufl, S. Heher, G. Prager, R. Katzenschlager, C. Abela, B. Niederle, T. Stefenelli, Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin. Endocrinol. 53(2), 229–233 (2000)CrossRef
25.
Zurück zum Zitat J.A. Rodriguez-Portales, C. Fardella, Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure. J. Endocrinol. Invest. 17(5), 307–311 (1994)CrossRefPubMed J.A. Rodriguez-Portales, C. Fardella, Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure. J. Endocrinol. Invest. 17(5), 307–311 (1994)CrossRefPubMed
26.
Zurück zum Zitat N. Garcia de la Torre, J.A.H. Wass, H.E. Turner, Parathyroid adenomas and cardiovascular risk. Endocr. Relat. Cancer. 10(2), 309–322 (2003)CrossRefPubMed N. Garcia de la Torre, J.A.H. Wass, H.E. Turner, Parathyroid adenomas and cardiovascular risk. Endocr. Relat. Cancer. 10(2), 309–322 (2003)CrossRefPubMed
27.
Zurück zum Zitat S.D. Pierdomenico, M. Di Nicola, A.L. Esposito, R. Di Mascio, E. Ballone, D. Lapenna, F. Cuccurullo, Prognostic value of different indices of blood pressure variability in hypertensive patients. Am. J. Hypertens. 22, 842–847 (2009)CrossRefPubMed S.D. Pierdomenico, M. Di Nicola, A.L. Esposito, R. Di Mascio, E. Ballone, D. Lapenna, F. Cuccurullo, Prognostic value of different indices of blood pressure variability in hypertensive patients. Am. J. Hypertens. 22, 842–847 (2009)CrossRefPubMed
28.
Zurück zum Zitat S.C. Malpas, Neural influences on cardiovascular variability:possibilities and pitfalls. Am. J. Physiol. Heart Circ. Physiol. 282, H6–H20 (2002)CrossRefPubMed S.C. Malpas, Neural influences on cardiovascular variability:possibilities and pitfalls. Am. J. Physiol. Heart Circ. Physiol. 282, H6–H20 (2002)CrossRefPubMed
29.
Zurück zum Zitat T.N. Thrasher, Baroreceptors and the long-term control of blood pressure. Exp. Physiol. 89, 331–335 (2004)CrossRefPubMed T.N. Thrasher, Baroreceptors and the long-term control of blood pressure. Exp. Physiol. 89, 331–335 (2004)CrossRefPubMed
30.
Zurück zum Zitat S.G. Massry, M. Smogorzewski, The effects of serum calcium and parathyroid hormone and the interaction between them on blood pressure in normal subjects and in patients with chronic kidney failure. J. Ren. Nutr. 15, 173–177 (2005)CrossRefPubMed S.G. Massry, M. Smogorzewski, The effects of serum calcium and parathyroid hormone and the interaction between them on blood pressure in normal subjects and in patients with chronic kidney failure. J. Ren. Nutr. 15, 173–177 (2005)CrossRefPubMed
31.
Zurück zum Zitat G.A. Nickols, Increased cyclic amp in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone. Eur. J. Pharmacol. 116, 137–144 (1985)CrossRefPubMed G.A. Nickols, Increased cyclic amp in cultured vascular smooth muscle cells and relaxation of aortic strips by parathyroid hormone. Eur. J. Pharmacol. 116, 137–144 (1985)CrossRefPubMed
32.
Zurück zum Zitat G. Rashid, J. Bernheim, J. Green, S. Benchetrit, Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol. Dial. Transplant. 22, 2831–2837 (2007)CrossRefPubMed G. Rashid, J. Bernheim, J. Green, S. Benchetrit, Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol. Dial. Transplant. 22, 2831–2837 (2007)CrossRefPubMed
33.
Zurück zum Zitat A. Virdis, F. Cetani, C. Giannarelli, C. Banti, L. Ghiadoni, E. Ambrogini, D. Carrara, A. Pinchera, S. Taddei, G. Bernini, C. Marcocci, The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism: effect of surgical treatment. J. Clin. Endocrinol. Metab. 95, 920–927 (2010)CrossRefPubMed A. Virdis, F. Cetani, C. Giannarelli, C. Banti, L. Ghiadoni, E. Ambrogini, D. Carrara, A. Pinchera, S. Taddei, G. Bernini, C. Marcocci, The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism: effect of surgical treatment. J. Clin. Endocrinol. Metab. 95, 920–927 (2010)CrossRefPubMed
34.
Zurück zum Zitat M.R. Rubin, M.S. Maurer, D.J. McMahon, J.P. Bilezikian, S.J. Silverberg, Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 90, 3326–3330 (2005)CrossRefPubMed M.R. Rubin, M.S. Maurer, D.J. McMahon, J.P. Bilezikian, S.J. Silverberg, Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 90, 3326–3330 (2005)CrossRefPubMed
35.
Zurück zum Zitat J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappe, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162, 331–339.e2 (2011)CrossRefPubMed J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappe, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162, 331–339.e2 (2011)CrossRefPubMed
36.
Zurück zum Zitat E. Hagstrom, E. Ingelsson, J. Sundstrom, P. Hellman, T.E. Larsson, L. Berglund, H. Melhus, C. Held, K. Michaelsson, L. Lind, J. Arnlov, Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur. J. Heart. Fail. 12, 1186–1192 (2010)CrossRefPubMed E. Hagstrom, E. Ingelsson, J. Sundstrom, P. Hellman, T.E. Larsson, L. Berglund, H. Melhus, C. Held, K. Michaelsson, L. Lind, J. Arnlov, Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur. J. Heart. Fail. 12, 1186–1192 (2010)CrossRefPubMed
37.
Zurück zum Zitat N. Levi-Marpillat, I. Macquin-Mavier, A.I. Tropeano, G. Parati, P. Maison, Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Hypertens. Res. 37, 585–590 (2014)CrossRefPubMed N. Levi-Marpillat, I. Macquin-Mavier, A.I. Tropeano, G. Parati, P. Maison, Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Hypertens. Res. 37, 585–590 (2014)CrossRefPubMed
38.
Zurück zum Zitat G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 218, 96–101 (2011)CrossRefPubMed G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 218, 96–101 (2011)CrossRefPubMed
39.
Zurück zum Zitat J. Bollerslev, C. Marcocci, M. Sosa, J. Nordenström, R. Bouillon, L. Mosekilde, Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur. J. Endocrinol. 165, 851–864 (2011)CrossRefPubMed J. Bollerslev, C. Marcocci, M. Sosa, J. Nordenström, R. Bouillon, L. Mosekilde, Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur. J. Endocrinol. 165, 851–864 (2011)CrossRefPubMed
40.
Zurück zum Zitat A. Persson, J. Bollerslev, T. Rosen, C.L. Mollerup, C. Franco, G.A. Isaksen, T. Ueland, S. Jansson, K. Caidahl; SIPH Study Group, Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism. Clin. Endocrinol. 74, 174–10 (2011)CrossRef A. Persson, J. Bollerslev, T. Rosen, C.L. Mollerup, C. Franco, G.A. Isaksen, T. Ueland, S. Jansson, K. Caidahl; SIPH Study Group, Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism. Clin. Endocrinol. 74, 174–10 (2011)CrossRef
Metadaten
Titel
Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism
verfasst von
A. Concistrè
A. Grillo
G. La Torre
R. Carretta
B. Fabris
L. Petramala
C. Marinelli
A. Rebellato
F. Fallo
C. Letizia
Publikationsdatum
12.07.2017
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1362-x

Weitere Artikel der Ausgabe 1/2018

Endocrine 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.